Morgan Stanley Insight Fund RPRX Holdings History
Morgan Stanley Insight Fund's Royalty Pharma PLC Holding Summary
As of 2025-03-31, Morgan Stanley Insight Fund held 1.95 Mil shares of Royalty Pharma PLC(RPRX), totaling $60.77 Mil. This investment constitutes 5.17% of their stock portfolio, and Morgan Stanley Insight Fund now holds 0.46% of the outstanding Royalty Pharma PLC(RPRX) stock.
The initial trade took place in 2020Q4. And since then Morgan Stanley Insight Fund has made 4 purchases of RPRX, at an average price of $44.51, for a total of 6.23 Mil shares. In addition, there have been 11 sales at an average price of $38.23 for 4.28 Mil shares. Based on historical transaction data and RPRX's current price of $35.47, Morgan Stanley Insight Fund's estimated gain on his RPRX holdings is $-44.53 Mil, reflecting a -16.06% gain to date.
Morgan Stanley Insight Fund RPRX ($35.47) Holding Chart
Morgan Stanley Insight Fund RPRX ($35.47) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
